Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Comabella

Showing results (91-100 of 263) with videos related to

Pageof 27
Sort By:
Journal of Neuroimmunology|May 6, 2014
Activation-induced cell death in T lymphocytes from multiple sclerosis patientsMontserrat Moreno, Laura Negrotto, Jordi Río, et al.
Archives of Neurology|January 16, 2008
Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosisEsther Byun, Stacy J Caillier, Xavier Montalban, et al.
Pharmacogenomics|May 20, 2009
United Europeans for development of pharmacogenomics in multiple sclerosis networkKoen Vandenbroeck, Manuel Comabella, Eva Tolosa, et al.
Multiple Sclerosis and Related Disorders|January 1, 2025
Etiological and clinical characterization of longitudinally extensive spinal cord lesions: A 12-year tertiary center experienceMiguel Mas-Serrano, Pascual Elvira-Ruiz, Carlos José De-Miguel-Sánchez-de-Puerta, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 29, 2022
Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosisManuel Comabella, Jaume Sastre-Garriga, Pere Carbonell-Mirabent, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2015
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosisAitzkoa Lopez de Lapuente, María Jesús Pinto-Medel, Ianire Astobiza, et al.
Journal of Medical Genetics|April 22, 2014
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosisConcepción Núñez, M Carmen Cénit, Roberto Alvarez-Lafuente, et al.
Epigenomics|December 8, 2020
Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkersMaría Muñoz-San Martín, Sandra Torras, René Robles-Cedeño, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 13, 2021
Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple SclerosisBelinda Carrión, Yawei Liu, Mahdieh Hadi, et al.
European Journal of Neurology|May 15, 2023
The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patientsSunny Malhotra, Luciana Midaglia, Omar Chuquisana, et al.
Pageof 27

Showing results (91-100 of 263) with videos related to

Sort By:
Pageof 27
Journal of Neuroimmunology|May 6, 2014
Activation-induced cell death in T lymphocytes from multiple sclerosis patientsMontserrat Moreno, Laura Negrotto, Jordi Río, et al.
Archives of Neurology|January 16, 2008
Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosisEsther Byun, Stacy J Caillier, Xavier Montalban, et al.
Pharmacogenomics|May 20, 2009
United Europeans for development of pharmacogenomics in multiple sclerosis networkKoen Vandenbroeck, Manuel Comabella, Eva Tolosa, et al.
Multiple Sclerosis and Related Disorders|January 1, 2025
Etiological and clinical characterization of longitudinally extensive spinal cord lesions: A 12-year tertiary center experienceMiguel Mas-Serrano, Pascual Elvira-Ruiz, Carlos José De-Miguel-Sánchez-de-Puerta, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 29, 2022
Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosisManuel Comabella, Jaume Sastre-Garriga, Pere Carbonell-Mirabent, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2015
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosisAitzkoa Lopez de Lapuente, María Jesús Pinto-Medel, Ianire Astobiza, et al.
Journal of Medical Genetics|April 22, 2014
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosisConcepción Núñez, M Carmen Cénit, Roberto Alvarez-Lafuente, et al.
Epigenomics|December 8, 2020
Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkersMaría Muñoz-San Martín, Sandra Torras, René Robles-Cedeño, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 13, 2021
Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple SclerosisBelinda Carrión, Yawei Liu, Mahdieh Hadi, et al.
European Journal of Neurology|May 15, 2023
The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patientsSunny Malhotra, Luciana Midaglia, Omar Chuquisana, et al.
Pageof 27